-
1
-
-
0010559484
-
-
note
-
2O, acetic anhydride; Al, allyl; Alloc, allyloxycarbonyl; BAL, backbone amide linker; Bu, butyl; Bzl, benzyl; Ddz, 2-(3,5-dimethoxyphenyl)propyl[2]oxycarbonyl; DIEA, N,N-diisopropylethylamine; DKP, diketopiperazine, (2,5-piperazinedione); DMF, N,N-dimethylformamide; Fmoc, 9-fluorenylmethoxycarbonyl; HATU, N-[(dimethylamino)-1H-1,2,3-triazolo-[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate N-oxide; HPLC, high performance liquid chromatography; IRAA, internal reference amino acid; Mtt, 4-methyltrityl; MALDI-TOF, matrix assisted laser desorption ionization, time of flight; PALdehyde, 5-(4-formyl-3,5-dimethoxyphenoxy)valeric acid; PEG-PS, polyethylene glycol-polystyrene graft; PS, polystyrene; PyAOP, 7-azabenzotriazol-1-yl-oxytris(pyrrolidino)phosphonium hexafluorophosphate; TFA, trifluoroacetic acid; THF, tetrahydrofuran; Trt, triphenylmethyl (trityl). Amino acid symbols denote L-configuration unless otherwise noted.
-
-
-
-
2
-
-
0010557862
-
-
note
-
2. Present address: Department of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
-
-
-
-
5
-
-
0003841613
-
-
Chaiken, I.M.; Janda, K.D., Eds., ACS Books: Washington
-
(c) Molecular Diversity and Combinatorial Chemistry. Libraries and Drug Discovery, Chaiken, I.M.; Janda, K.D., Eds., ACS Books: Washington, 1996;
-
(1996)
Molecular Diversity and Combinatorial Chemistry. Libraries and Drug Discovery
-
-
-
6
-
-
0003702003
-
-
Wilson, S.H.; Czarnik, A.W., Eds., Wiley & Sons: New York
-
(d) Combinatorial Chemistry: Synthesis and Applications, Wilson, S.H.; Czarnik, A.W., Eds., Wiley & Sons: New York, 1997;
-
(1997)
Combinatorial Chemistry: Synthesis and Applications
-
-
-
7
-
-
0003703778
-
-
DeWitt, S.H.; Czarnik, A.W. Eds., ACS Books: Washington
-
(e) A Practical Guide to Combinatorial Chemistry, DeWitt, S.H.; Czarnik, A.W. Eds., ACS Books: Washington, 1997.
-
(1997)
A Practical Guide to Combinatorial Chemistry
-
-
-
9
-
-
0001791958
-
-
Grant, G.A. Ed.; W. H. Freeman and Company: New York
-
(b) Fields, G.B.; Tian, Z.; Barany, G. In Synthetic Peptides. A User's Guide; Grant, G.A. Ed.; W. H. Freeman and Company: New York, 1992; pp 77-183;
-
(1992)
Synthetic Peptides. A User's Guide
, pp. 77-183
-
-
Fields, G.B.1
Tian, Z.2
Barany, G.3
-
11
-
-
0030599282
-
-
5. Cui, C-B.; Kakeya, H.; Osada, H. (a) Tetrahedron 1996, 52, 12651-12666;
-
(1996)
Tetrahedron
, vol.52
, pp. 12651-12666
-
-
Cui, C.-B.1
Kakeya, H.2
Osada, H.A.3
-
12
-
-
0030036459
-
-
(b) J. Antibiot. 1996, 49, 534-540.
-
(1996)
J. Antibiot.
, vol.49
, pp. 534-540
-
-
-
13
-
-
0029894647
-
-
6. Charlton, P.A.; Faint, R.W.; Bent, F.; Bryans, J.; Chicarelli-Robinson, I.; Mackie, I.; Machin, S.; Bevan, P. Thromb. Haemost. 1996, 75, 808-815.
-
(1996)
Thromb. Haemost.
, vol.75
, pp. 808-815
-
-
Charlton, P.A.1
Faint, R.W.2
Bent, F.3
Bryans, J.4
Chicarelli-Robinson, I.5
Mackie, I.6
Machin, S.7
Bevan, P.8
-
14
-
-
0028171012
-
-
7. Funabashi, Y.; Horiguchi, T.; Iinuma, S.; Tanida, S.; Harada, S. J. Antibiot. 1994, 47, 1202-1218.
-
(1994)
J. Antibiot.
, vol.47
, pp. 1202-1218
-
-
Funabashi, Y.1
Horiguchi, T.2
Iinuma, S.3
Tanida, S.4
Harada, S.5
-
15
-
-
0028878426
-
-
8. Barrow, C.J.; Musza, L.L.; Cooper, R. Bioorg. Med. Chem. Lett. 1995, 5, 377-380.
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 377-380
-
-
Barrow, C.J.1
Musza, L.L.2
Cooper, R.3
-
16
-
-
0343484482
-
-
9. (a) Weng, J.H.; Bado, A.; Garbay, C.; Roques, B.P. Reg. Pept. 1996, 65, 3-9;
-
(1996)
Reg. Pept.
, vol.65
, pp. 3-9
-
-
Weng, J.H.1
Bado, A.2
Garbay, C.3
Roques, B.P.4
-
17
-
-
0030252432
-
-
(b) Goodfellow, V.S.; Laudeman, C.P.; Gerrity, J.I.; Burkard, M.; Strobel, E.; Zuzack, J.S.; McLeod, D.A. Mol. Diver. 1996, 2, 97-102.
-
(1996)
Mol. Diver.
, vol.2
, pp. 97-102
-
-
Goodfellow, V.S.1
Laudeman, C.P.2
Gerrity, J.I.3
Burkard, M.4
Strobel, E.5
Zuzack, J.S.6
McLeod, D.A.7
-
18
-
-
0010626422
-
-
in ref. 4c
-
10. Solid-phase strategies for DKP synthesis have been described previously, but are not as versatile as the strategy shown in the present work. Thus, our strategy allows use of any combination of amino acids, unlike a scheme that starts by anchoring Asp or Glu to an appropriate resin: Krchnák, V.; Weichsel, A.S.; Cabel, D.; Lebl, M. in ref. 4c pp. 99-117, nor is the presence of an N-alkylamino acid mandatory to favor the cyclization as described by: Gordon, D.W.; Steele, J. Bioorg. Med. Chem. Lett. 1995, 5, 47-50; Szardenings, A.K.; Burkoth, T.S.; Lu, H.H.; Tien, D.W.; Campbell, D.A. Tetrahedron 1997, 53, 6573-6593.
-
-
-
Krchnák, V.1
Weichsel, A.S.2
Cabel, D.3
Lebl, M.4
-
19
-
-
0028833961
-
-
10. Solid-phase strategies for DKP synthesis have been described previously, but are not as versatile as the strategy shown in the present work. Thus, our strategy allows use of any combination of amino acids, unlike a scheme that starts by anchoring Asp or Glu to an appropriate resin: Krchnák, V.; Weichsel, A.S.; Cabel, D.; Lebl, M. in ref. 4c pp. 99-117, nor is the presence of an N-alkylamino acid mandatory to favor the cyclization as described by: Gordon, D.W.; Steele, J. Bioorg. Med. Chem. Lett. 1995, 5, 47-50; Szardenings, A.K.; Burkoth, T.S.; Lu, H.H.; Tien, D.W.; Campbell, D.A. Tetrahedron 1997, 53, 6573-6593.
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 47-50
-
-
Gordon, D.W.1
Steele, J.2
-
20
-
-
0031000559
-
-
10. Solid-phase strategies for DKP synthesis have been described previously, but are not as versatile as the strategy shown in the present work. Thus, our strategy allows use of any combination of amino acids, unlike a scheme that starts by anchoring Asp or Glu to an appropriate resin: Krchnák, V.; Weichsel, A.S.; Cabel, D.; Lebl, M. in ref. 4c pp. 99-117, nor is the presence of an N-alkylamino acid mandatory to favor the cyclization as described by: Gordon, D.W.; Steele, J. Bioorg. Med. Chem. Lett. 1995, 5, 47-50; Szardenings, A.K.; Burkoth, T.S.; Lu, H.H.; Tien, D.W.; Campbell, D.A. Tetrahedron 1997, 53, 6573-6593.
-
(1997)
Tetrahedron
, vol.53
, pp. 6573-6593
-
-
Szardenings, A.K.1
Burkoth, T.S.2
Lu, H.H.3
Tien, D.W.4
Campbell, D.A.5
-
23
-
-
0015527159
-
-
(c) Khosla, M. C.; Smeby, R. R.; Bumpus, F. J. Am. Chem. Soc. 1972, 94, 4721-4724;
-
(1972)
J. Am. Chem. Soc.
, vol.94
, pp. 4721-4724
-
-
Khosla, M.C.1
Smeby, R.R.2
Bumpus, F.3
-
25
-
-
0001293516
-
-
(e) Giralt, E.; Eritja, R.; Pedroso, E. Tetrahedron Lett. 1981, 22, 3779-3782;
-
(1981)
Tetrahedron Lett.
, vol.22
, pp. 3779-3782
-
-
Giralt, E.1
Eritja, R.2
Pedroso, E.3
-
27
-
-
85008894386
-
-
(g) Pedroso, E.; Grandas, A.; de las Heras, X.; Eritja, R.; Giralt, E. Tetrahedron Lett. 1986, 27, 743-746;
-
(1986)
Tetrahedron Lett.
, vol.27
, pp. 743-746
-
-
Pedroso, E.1
Grandas, A.2
De Las Heras, X.3
Eritja, R.4
Giralt, E.5
-
28
-
-
0028300132
-
-
(h) Fischer, P.M.; Solbakken, M.; Undheim, K. Tetrahedron 1994, 50, 2277-2288;
-
(1994)
, vol.50
, pp. 2277-2288
-
-
Fischer, P.M.1
Solbakken, M.2
Undheim, K.T.3
-
29
-
-
0028338351
-
-
(i) Lloyd-Williams, P.; Merzouk, A.; Guibé, F.; Albericio, F.; Giralt, E. Tetrahedron Lett. 1994, 35, 4437-4440.
-
(1994)
Tetrahedron Lett.
, vol.35
, pp. 4437-4440
-
-
Lloyd-Williams, P.1
Merzouk, A.2
Guibé, F.3
Albericio, F.4
Giralt, E.5
-
30
-
-
0016607330
-
-
12. (a) Suzuki, K.; Nitta, K.; Endo, N. Chem. Pharm. Bull. 1975, 23, 222-224;
-
(1975)
Chem. Pharm. Bull.
, vol.23
, pp. 222-224
-
-
Suzuki, K.1
Nitta, K.2
Endo, N.3
-
31
-
-
0025678431
-
-
(b) Gairí, M.; Lloyd-Williams, P.; Albericio, F.; Giralt, E. Tetrahedron Lett. 1990, 31, 7363-7366;
-
(1990)
Tetrahedron Lett.
, vol.31
, pp. 7363-7366
-
-
Gairí, M.1
Lloyd-Williams, P.2
Albericio, F.3
Giralt, E.4
-
32
-
-
0030012632
-
-
(c) Alsina, J.; Giralt, E.; Albericio, F. Tetrahedron Lett. 1996, 37, 4195-4198.
-
(1996)
Tetrahedron Lett.
, vol.37
, pp. 4195-4198
-
-
Alsina, J.1
Giralt, E.2
Albericio, F.3
-
33
-
-
0002469361
-
-
Kaumaya, P.T.P.; Hodges, R.S. Eds.; Mayflower Worldwide Ltd., Kingswinford, England
-
13. Jensen, K.J.; Alsina, J.; Songster, M.F.; Vágner, J.; Albericio, F.; Barany, G. (a) In Peptides-Chemistry and Biology: Proceedings of the 14th American Peptide Symposium; Kaumaya, P.T.P.; Hodges, R.S. Eds.; Mayflower Worldwide Ltd., Kingswinford, England, 1996, pp 30-32;
-
(1996)
Peptides-chemistry and Biology: Proceedings of the 14th American Peptide Symposium
, pp. 30-32
-
-
Jensen, K.J.1
Alsina, J.2
Songster, M.F.3
Vágner, J.4
Albericio, F.5
Barany, G.A.6
-
34
-
-
0010592872
-
-
submitted for publication
-
(b) J. Am. Chem. Soc. submitted for publication.
-
J. Am. Chem. Soc.
-
-
-
35
-
-
0010625942
-
-
note
-
14. Built into the BAL approach (see text structure), the anchored first amino acid ester is N-alkylated and therefore more likely to form a DKP at the dipeptidyl ester stage.
-
-
-
-
36
-
-
0010629184
-
-
note
-
α-Fmoc derivative under in situ neutralization/coupling conditions mediated by PyAOP in DMF in the presence of DIEA (see ref. 12c and 13).
-
-
-
-
37
-
-
0025032015
-
-
16. Albericio, F.; Kneib-Cordonier, N.; Biancalana, S.; Gera, L.; Masada, R.I.; Hudson, D.; Barany, G. J. Org Chem. 1990, 55, 3730-3743.
-
(1990)
J. Org Chem.
, vol.55
, pp. 3730-3743
-
-
Albericio, F.1
Kneib-Cordonier, N.2
Biancalana, S.3
Gera, L.4
Masada, R.I.5
Hudson, D.6
Barany, G.7
-
38
-
-
33845312505
-
-
were dissolved in DMF, then DIEA (8 equiv) was added, and after 1 min preactivation, this solution was added to amino-functionalized PS or PEG-PS-resin also containing an IRAA. Coupling was allowed to proceed at 25 °C for 2 h, at which time the resin was negative to the Kaiser ninhydrin test
-
17. PALdehyde (4 equiv) and HATU (4 equiv) (Carpino, L.A.; El-Faham, A.; Minor, C.A.; Albericio, F. J. Chem. Soc., Chem. Commun. 1994, 201-203) were dissolved in DMF, then DIEA (8 equiv) was added, and after 1 min preactivation, this solution was added to amino-functionalized PS or PEG-PS-resin also containing an IRAA. Coupling was allowed to proceed at 25 °C for 2 h, at which time the resin was negative to the Kaiser ninhydrin test.
-
(1994)
J. Chem. Soc., Chem. Commun.
, pp. 201-203
-
-
Carpino, L.A.1
El-Faham, A.2
Minor, C.A.3
Albericio, F.4
-
39
-
-
0010593535
-
-
note
-
18. Methyl ester of all amino acids are commercially available. The same chemistry was also successful for other esters; in particular the rates and yields of DKP formation (step i) were shown to be very similar for methyl, allyl, and benzyl esters.
-
-
-
-
40
-
-
0010557863
-
-
note
-
2 and MeOH, and finally dried. These conditions assure complete integrity of the amino acyl chiral center.
-
-
-
-
41
-
-
0010557576
-
-
note
-
2O-DMF (1:9, 20 min), and washed with DMF.
-
-
-
-
42
-
-
0010592012
-
-
note
-
21. Treatments with piperidine-DMF (1:4) were followed by washes with DMF. At this stage, the Kaiser ninhydrin test was in all cases negative.
-
-
-
-
43
-
-
0010593536
-
-
note
-
22. Yields were determined to be greater than 95%, as follows: Upon completion of the DKP-forming reaction, a third Fmoc-amino acid was coupled, and resin was subjected to acid hydrolysis followed by AAA. The ratio between this third amino acid and the initial two gave the amount of free amine, and could then be used to calculate the overall yield of DKP formation.
-
-
-
-
45
-
-
0017784004
-
-
and ref. 11f
-
24. An orthogonal system is defined as a set of completely independent classes of protecting groups, such that each class of groups can be removed in any order and in the presence of all other class (Barany, G.; Merrifield, R.B. J. Am. Chem. Soc. 1977, 99, 7363-7365; and ref. 11f).
-
(1977)
J. Am. Chem. Soc.
, vol.99
, pp. 7363-7365
-
-
Barany, G.1
Merrifield, R.B.2
-
46
-
-
0010625943
-
-
note
-
3CN and 0.1% aqueous TFA, from 1:9 to 1:0, over 30 min, run at 1.0 mL/min. UV detection was at 220 nm. All DKPs studied showed purity similar to the example of DKP (5).
-
-
-
|